摘要
The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (GEF) has been used to treat nonsmall-cell lung cancer (NSCLC); yet, the curative effect of GEF was compromised by drug resistance. Herein, an EGFR aptamer-modified therapeutic strategy (Apt/(siRNA + GEF)@ZIF-8 nanoparticles (NPs)) was fabricated by employing zeolitic imidazolate framework-8 (ZIF-8)-based metal-organic frameworks for targeted delivery of GEF and EGFR siRNA to suppress the drug-resistant gene expression in tumors. Apt/(siRNA + GEF)@ZIF-8 NPs had a high loading efficiency for GEF and siRNA, and the particle size was about 75 nm with a stable crystal structure. In vitro experiments showed that GEF cooperating with siRNA could promote cell apoptosis and displayed a synergistic therapeutic effect on drug-resistant cancer cells. In vivo biodistribution study demonstrated that Apt/(siRNA + GEF)@ZIF-8 could be enriched at tumor sites successfully, which provided a basis for in vivo antitumor experiments. In vivo experiment illustrated that the NPs with good biocompatibility had a high efficiency for conquering the acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC with a tumor inhibition rate of 40.6%. Overall, the findings from this study implied that this biological target nanodrug therapy may provide a promising approach for the treatment of drug-resistant NSCLC.
学科与关键词
- An Activatable Nano-Prodrug for Treating Tyrosine-Kinase-Inhibitor-Resistant Non-Small Cell Lung Cancer and for Optoacoustic and Fluorescent ImagingXie, Xin; Zhan, Chenyue; Wang, Jie; Zeng, Fang*; Wu, Shuizhu*Small, 2020, 16(38): 2003451.被引 22
- A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapyXu, Bin; Zeng, Fanjun; Deng, Jialong; Yao, Lintong; Liu, Shengbo; Hou, Hengliang; Huang, Yucheng; Zhu, Hongyuan; Wu, Shaowei; Li, Qiaxuan; Zhan, Weijie; Qiu, Hongrui; Wang, Huili; Li, Yundong; Yang, Xianzhu; Cao, Ziyang*; Zhang, Yu*; Zhou, Haiyu*Bioactive Materials, 2023, 27: 337-347.被引 5
- Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancerDiao, Dingwei; Zhai, Jianxue; Yang, Jianjun; Wu, Hua; Jiang, Jianjun; Dong, Xiaoying; Passaro, Antonio; Aramini, Beatrice; Rao, Shuan*; Cai, Kaican*Translational Lung Cancer Research, 2021, 10(2): 926-935.被引 5
